OM1
OM1 Employees
13 people indexed:
-
Carl Marci
Chief Clinical Officer, Chief Psychiatrist and Managing Director of Mental Health and Neuroscience
3ukjnq@2wd.9f7 Sign up to see email0udjxb@kg7.52s Sign up to see email -
x9gxn60yr@q83.5dh Sign up to see email
-
w98au@fjs.q4w Sign up to see email
-
txhp9ua@h38.pk7 Sign up to see email
-
nplybiwg@ad9.7lx Sign up to see email
-
269frgg6d@gt2.738 Sign up to see email
-
5vdw4d6x@inn.ijp Sign up to see email
-
38fxb0u06@ppl.8ap Sign up to see email
-
dv3dp2q@gj8.7gt Sign up to see email
-
0t5tyts6q@p3b.864 Sign up to see email
-
vhf3q7@qhr.000 Sign up to see email
-
Sonja Wustrack
Managing Director of Integrated Evidence Generation
5vyjxdh32@j3z.3qf Sign up to see emailnj62xjpfj@579.nl9 Sign up to see email -
pkx6w5@dh8.43z Sign up to see email
OM1 Company Information
OM1 is a company that specializes in leveraging real-world data and artificial intelligence to advance medical research and personalized medicine. The company provides solutions in real-world evidence, AI and predictive medicine, and outcomes measurement. OM1 offers specialty data networks in various medical fields, including immunology, mental health & neuroscience, cardiometabolic, dermatology, gastroenterology, respiratory/ENT, and rheumatology. The company’s platform, PhenOM, supports AI and predictive medicine with products such as OM1 Orion, OM1 Lyra, and OM1 Polaris. OM1 also hosts a variety of resources, including publications, blogs, and webinars focused on healthcare analytics and real-world evidence. The company engages in partnerships with leading pharmaceutical and medical device companies and utilizes a patented AI platform for its products and services. Recently, OM1 launched three new products powered by its patented AI platform to expedite the delivery of personalized medicine.